Search

Search Constraints

You searched for: Author/Creator Luquet, Isabelle

Search Results

1. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma. Issue 8 (12th April 2014)

2. Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study. Issue 6 (12th May 2022)

5. Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. (13th December 2020)

6. Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype. Issue 7 (6th June 2020)

7. Dactinomycin in acute myeloid leukemia with NPM1 mutations. (25th May 2020)

8. Impact of obesity in favorable‐risk AML patients receiving intensive chemotherapy. Issue 2 (26th November 2015)

9. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial. (18th April 2021)

10. More than ten percent of relapses occur after five years in AML patients with NPM1 mutation. Issue 5 (15th April 2020)